• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EQ-5D在哮喘中的有效性和反应性:一项系统评价和荟萃分析。

Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis.

作者信息

Chua Ai-Ping, Cheng Ling Jie, Soh Zhi Yi, Chen Le Ann, Luo Nan

机构信息

Department of Medicine, JurongHealth Campus, National University Health System, 1 Jurong East Street 21, Singapore, 609606, Singapore.

Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.

出版信息

Patient. 2025 Jan;18(1):35-47. doi: 10.1007/s40271-024-00711-9. Epub 2024 Sep 7.

DOI:10.1007/s40271-024-00711-9
PMID:39243353
Abstract

OBJECTIVE

We aimed to synthesize the evidence on the construct validity and responsiveness of the EQ-5D and compare them with asthma-specific health-related quality-of-life scales, to guide further research and clinical applications in asthma.

METHODS

We searched key databases from inception to 1 June, 2024 and used the COnsensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) method to appraise the evidence. The effect size estimates were aggregated using the inverse variance method to evaluate the relative efficiency of EQ-5D measures against the Asthma Quality of Life Questionnaire (AQLQ) and/or its corresponding preference-based index, Asthma Quality of Life-5 Dimensions (AQL-5D).

RESULTS

There were 493 tests (construct validity: 428; responsiveness: 65) drawn from 37 selected articles (validation: 7; clinical: 30). Overall, 78.4% and 76.9% of the a priori hypotheses for assessing construct validity (convergent validity: 56.4%; known groups: 88.5%) and responsiveness, respectively, were satisfied. The methodological quality was "very good" or "adequate" in 78.2% of construct validity tests and 92.3% of responsiveness tests. The pooled correlation coefficient between EQ-5D index and AQLQ total scores was 0.52 (95% confidence interval 0.43-0.59), and between EQ visual analog scale and AQLQ total scores was 0.53 (95% confidence interval 0.34-0.69). The Cohen's d ratios for the index, level sum scores, and visual analog scale compared to AQLQ were 0.56 (n = 27), 1.16 (n = 16), and 0.75 (n = 37). The EQ-5D index's Cohen's d ratio compared to AQL-5D was 0.49 (n = 5). The standardized response mean ratios for the index and visual analog scale compared to AQLQ were 0.26 (n = 11) and 0.63 (n = 9).

CONCLUSIONS

The EQ-5D demonstrated overall good validity and responsiveness in the adult asthma population. However, a comparison against disease-specific instruments suggested scope for improvement in its psychometric performance for this population.

摘要

目的

我们旨在综合关于EQ-5D的结构效度和反应度的证据,并将其与哮喘特异性健康相关生活质量量表进行比较,以指导哮喘领域的进一步研究和临床应用。

方法

我们检索了从起始到2024年6月1日的主要数据库,并使用基于共识的健康测量工具选择标准(COSMIN)方法来评估证据。使用逆方差法汇总效应量估计值,以评估EQ-5D测量相对于哮喘生活质量问卷(AQLQ)和/或其相应的基于偏好的指数哮喘生活质量-5维度(AQL-5D)的相对效率。

结果

从37篇选定文章(验证:7篇;临床:30篇)中提取了493项测试(结构效度:428项;反应度:65项)。总体而言,评估结构效度(收敛效度:56.4%;已知组:88.5%)和反应度的先验假设分别有78.4%和76.9%得到满足。在78.2%的结构效度测试和92.3%的反应度测试中,方法学质量为“非常好”或“充分”。EQ-5D指数与AQLQ总分之间的合并相关系数为0.52(95%置信区间0.43 - 0.59),EQ视觉模拟量表与AQLQ总分之间的合并相关系数为0.53(95%置信区间0.34 - 0.69)。与AQLQ相比,指数、水平总和分数和视觉模拟量表的科恩d比率分别为0.56(n = 27)、1.16(n = 16)和0.75(n = 37)。与AQL-5D相比,EQ-5D指数的科恩d比率为0.49(n = 5)。与AQLQ相比,指数和视觉模拟量表的标准化反应均值比率分别为0.26(n = 11)和0.63(n = 9)。

结论

EQ-5D在成年哮喘人群中总体显示出良好的效度和反应度。然而,与疾病特异性工具的比较表明,其在该人群中的心理测量性能仍有改进空间。

相似文献

1
Validity and Responsiveness of EQ-5D in Asthma: A Systematic Review and Meta-analysis.EQ-5D在哮喘中的有效性和反应性:一项系统评价和荟萃分析。
Patient. 2025 Jan;18(1):35-47. doi: 10.1007/s40271-024-00711-9. Epub 2024 Sep 7.
2
The construct validity and responsiveness of the EQ-5D-5L, AQL-5D and a bespoke TTO in acute asthmatics.急性哮喘患者 EQ-5D-5L、AQL-5D 和定制 TTO 的结构效度和反应度。
Qual Life Res. 2020 Mar;29(3):619-627. doi: 10.1007/s11136-019-02345-z. Epub 2019 Nov 2.
3
How does the EQ-5D-5L perform in asthma patients compared with an asthma-specific quality of life questionnaire?EQ-5D-5L 在哮喘患者中的表现与哮喘特异性生活质量问卷相比如何?
BMC Pulm Med. 2020 Jun 13;20(1):168. doi: 10.1186/s12890-020-01205-8.
4
Are condition-specific utilities more valid than generic preference-based ones in asthma? Evidence from a study comparing EQ-5D-3L and SF-6D with AQL-5D.在哮喘中,特定疾病效用值是否比基于通用偏好的效用值更有效?一项比较EQ-5D-3L、SF-6D与AQL-5D的研究证据。
Expert Rev Pharmacoecon Outcomes Res. 2018 Dec;18(6):667-675. doi: 10.1080/14737167.2018.1505506. Epub 2018 Aug 3.
5
The EORTC QLU-C10D distinguished better between cancer patients and the general population than PROPr and EQ-5D-5L in a cross-sectional study.在一项横断面研究中,与PROPr和EQ-5D-5L相比,欧洲癌症研究与治疗组织生活质量问卷核心10项(EORTC QLU-C10D)能更好地区分癌症患者和普通人群。
J Clin Epidemiol. 2025 Jan;177:111592. doi: 10.1016/j.jclinepi.2024.111592. Epub 2024 Nov 7.
6
Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.适用于 2 至 4 岁儿童的 EQ-5D-Y-3L 和 -Y-5L 中文版和英文版在代理应答者中的心理测量性能比较。
Pharmacoeconomics. 2024 Jun;42(Suppl 1):129-145. doi: 10.1007/s40273-024-01350-6. Epub 2024 Jan 18.
7
Assessment of the construct validity and responsiveness of preference-based quality of life measures in people with Parkinson's: a systematic review.帕金森病患者基于偏好的生活质量测量工具的结构效度和反应度评估:一项系统评价
Qual Life Res. 2017 Jan;26(1):1-23. doi: 10.1007/s11136-016-1428-x. Epub 2016 Oct 24.
8
Measurement Properties of the EQ VAS Around the Globe: A Systematic Review and Meta-Regression Analysis.全球 EQ-5D 视觉模拟标尺测量属性的系统评价和荟萃回归分析。
Value Health. 2021 Aug;24(8):1223-1233. doi: 10.1016/j.jval.2021.02.003. Epub 2021 Apr 23.
9
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.骨折联络服务就诊的荷兰骨折患者中 EQ-5D-5L 与 SF-6D 的头对头比较。
J Med Econ. 2022 Jan-Dec;25(1):829-839. doi: 10.1080/13696998.2022.2087409.
10
Validity and measurement equivalence of EQ-5D-5L questionnaire among heart failure patients in Malaysia: a cohort study.马来西亚心力衰竭患者 EQ-5D-5L 问卷的有效性和测量等效性:一项队列研究。
J Med Econ. 2024 Jan-Dec;27(1):607-617. doi: 10.1080/13696998.2024.2337563. Epub 2024 Apr 13.

引用本文的文献

1
Determinants of Impaired Health-Related Quality of Life in Older Italian Outpatients with Type 2 Diabetes.意大利老年2型糖尿病门诊患者健康相关生活质量受损的决定因素
J Clin Med. 2025 Aug 29;14(17):6118. doi: 10.3390/jcm14176118.
2
Are EQ-5D-Y-3L and EQ-5D-Y-5L Useful Tools to Assess Health Outcomes in Children With Asthma? An Analysis of Child and Parental Carer Reporting.EQ-5D-Y-3L和EQ-5D-Y-5L是评估哮喘儿童健康结局的有用工具吗?一项儿童及家长报告的分析。
Pediatr Pulmonol. 2025 Mar;60(3):e71031. doi: 10.1002/ppul.71031.
3
Concurrent Validity Between EQ-5D and HRQ-6D Measures in Patients with Different Primary Diagnoses.

本文引用的文献

1
The Ceiling Effects of EQ-5D-3L and 5L in General Population Health Surveys: A Systematic Review and Meta-Analysis.EQ-5D-3L 和 5L 在一般人群健康调查中的天花板效应:系统评价和荟萃分析。
Value Health. 2024 Jul;27(7):986-997. doi: 10.1016/j.jval.2024.02.018. Epub 2024 Mar 10.
2
A cross-sectional study to evaluate utility measure and health-related quality of life (HRQoL) among patients with severe uncontrolled asthma in Spain.一项评估西班牙严重未控制哮喘患者效用测量和健康相关生活质量(HRQoL)的横断面研究。
J Asthma. 2024 Jan;61(1):27-38. doi: 10.1080/02770903.2023.2241891. Epub 2023 Sep 1.
3
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY.
不同原发性诊断患者中EQ-5D与HRQ-6D测量指标的同时效度
J Clin Med. 2024 Dec 26;14(1):64. doi: 10.3390/jcm14010064.
NOVELTY研究中未控制和已控制的重度哮喘患者的症状负担、健康状况及生产力
J Asthma Allergy. 2023 Jun 11;16:611-624. doi: 10.2147/JAA.S401445. eCollection 2023.
4
Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study.EQ-5D-5L Plus呼吸附加模块在伯明翰慢性阻塞性肺疾病队列研究中的表现。
Value Health. 2021 Nov;24(11):1667-1675. doi: 10.1016/j.jval.2021.05.006. Epub 2021 Aug 4.
5
Health-Related Quality of Life and Health Utilities of Mild, Moderate, and Severe Asthma: Evidence from the Medical Expenditure Panel Survey.轻度、中度和重度哮喘的健康相关生活质量与健康效用:来自医疗支出面板调查的证据。
J Asthma Allergy. 2021 Jul 28;14:929-941. doi: 10.2147/JAA.S316278. eCollection 2021.
6
Health related quality of life in adults with asthma: a systematic review to identify the values of EQ-5D-5L instrument.哮喘成人健康相关生命质量:系统评价以确定 EQ-5D-5L 工具的价值。
J Asthma. 2022 Jun;59(6):1203-1212. doi: 10.1080/02770903.2021.1917607. Epub 2021 May 8.
7
COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures.CONSORT 报告规范:用于评估患者报告结局测量工具测量属性的研究。
Qual Life Res. 2021 Aug;30(8):2197-2218. doi: 10.1007/s11136-021-02822-4. Epub 2021 Apr 5.
8
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews.《PRISMA 2020声明:报告系统评价的更新指南》
J Clin Epidemiol. 2021 Jun;134:178-189. doi: 10.1016/j.jclinepi.2021.03.001. Epub 2021 Mar 29.
9
Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience.贝那利珠单抗改善重度嗜酸性粒细胞性哮喘患者生活质量的有效性:我们的真实世界经验。
Front Pharmacol. 2021 Feb 12;12:631660. doi: 10.3389/fphar.2021.631660. eCollection 2021.
10
Relationship between health-related quality of life and subjective wellbeing in asthma.哮喘患者健康相关生活质量与主观幸福感的关系。
J Psychosom Res. 2021 Mar;142:110356. doi: 10.1016/j.jpsychores.2021.110356. Epub 2021 Jan 8.